Seroatlas · Human Serome Atlas

GP1BB

Platelet glycoprotein Ib beta chain

Also known as: CD42c, GP1BB_HUMAN, GPIbbeta

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P13224
Gene
GP1BB
Ensembl
ENSG00000203618
Chromosome
22
Canonical length
206 aa
Protein class
CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins

OverviewNCBI Gene

Platelet glycoprotein Ib (GPIb) is a heterodimeric transmembrane protein consisting of a disulfide-linked 140 kD alpha chain and 22 kD beta chain. It is part of the GPIb-V-IX system that constitutes the receptor for von Willebrand factor (VWF), and mediates platelet adhesion in the arterial circulation. GPIb alpha chain provides the VWF binding site, and GPIb beta contributes to surface expression of the receptor and participates in transmembrane signaling through phosphorylation of its intracellular domain. Mutations in the GPIb beta subunit have been associated with Bernard-Soulier syndrome, velocardiofacial syndrome and giant platelet disorder. The 206 amino acid precursor of GPIb beta is synthesized from a 1.0 kb mRNA expressed in plateletes and megakaryocytes. A 411 amino acid protein arising from a longer, unspliced transcript in endothelial cells has been described; however, the authenticity of this product has been questioned. Yet another less abundant GPIb beta mRNA species of 3.5 kb, expressed in nonhematopoietic tissues such as endothelium, brain and heart, was shown to result from inefficient usage of a non-consensus polyA signal in the neighboring upstream gene (SEPT5, septin 5). In the absence of polyadenylation from its own imperfect site, the SEPT5 gene produces read-through transcripts that use the consensus polyA signal of this gene. [provided by RefSeq, Dec 2010]

Canonical amino-acid sequenceUniProt

206 residues, UniProt reviewed canonical sequence.

>P13224|GP1BB
     1  MGSGPRGALS LLLLLLAPPS RPAAGCPAPC SCAGTLVDCG RRGLTWASLP TAFPVDTTEL
    61  VLTGNNLTAL PPGLLDALPA LRTAHLGANP WRCDCRLVPL RAWLAGRPER APYRDLRCVA
   121  PPALRGRLLP YLAEDELRAA CAPGPLCWGA LAAQLALLGL GLLHALLLVL LLCRLRRLRA
   181  RARARAAARL SLTDPLVAER AGTDES

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against GP1BB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.41
Highest tissue expression
93 nTPM

Expression across tissuesHPA

Tissue

  • basal ganglia: 93 nTPM
  • hippocampal formation: 75 nTPM
  • amygdala: 69 nTPM
  • cerebellum: 58 nTPM
  • cerebral cortex: 47 nTPM
  • hypothalamus: 25 nTPM

Single-cell type

  • brain inhibitory neurons: 59 nCPM
  • brain excitatory neurons: 44 nCPM
  • other brain neurons: 37 nCPM
  • oligodendrocyte progenitor cells: 30 nCPM
  • choroid plexus epithelial cells: 21 nCPM
  • ependymal cells: 18 nCPM

Immune cell

  • total PBMC: 418 nTPM
  • neutrophil: 75 nTPM
  • basophil: 74 nTPM
  • plasmacytoid DC: 13 nTPM
  • eosinophil: 13 nTPM
  • classical monocyte: 8.5 nTPM

Brain region

  • hippocampal formation: 119 nTPM
  • cerebral cortex: 111 nTPM
  • basal ganglia: 90 nTPM
  • amygdala: 88 nTPM
  • thalamus: 65 nTPM
  • cerebellum: 61 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about GP1BB.

Disease | AllUniProt

Conditions GP1BB is implicated in, by any mechanism.

Disease | GeneticClinVar

46 pathogenic / likely-pathogenic of 158 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.33
gnomAD pLI
0.51
gnomAD missense Z
0.46
DepMap mean gene effect
-0.2
DepMap dependency class
selective

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of GP1BB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads GP1BB as an antibody target. Whether an autoantibody or antibody against GP1BB could matter depends on whether native GP1BB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

GP1BB is annotated at the cell surface, where native GP1BB is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label GP1BB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/GP1BB. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...